, Verhoogde mortaliteit ...........................................................................................................................................................87
Valpreventie ............................................................................................................................................................ 87
Primaire valpreventie .............................................................................................................................................................88
Secundaire valpreventie ........................................................................................................................................................88
Klinische vragen ................................................................................................................................................................89
Oefenprogramma’s ......................................................................................................................................................93
Sleutelelementen van een goed oefenprogramma .....................................................................................................94
Doorverwijzen: ............................................................................................................................................................95
F-pathologie sinds maart 2007 ....................................................................................................................................95
Informatie en advies/WZC ...........................................................................................................................................96
Preventie van breuken ...........................................................................................................................................................96
10. LONGREVALIDATIE ....................................................................................................................................................... 97
Fysiologie ................................................................................................................................................................. 97
Normale veroudering .............................................................................................................................................. 98
Veel voorkomende aandoeningen ......................................................................................................................... 100
Pneumonie...........................................................................................................................................................................100
Atelectase ............................................................................................................................................................................101
COPD ....................................................................................................................................................................................102
Respiratoire kinesitherapie .................................................................................................................................... 103
Klinisch onderzoek ...............................................................................................................................................................103
Behandeling .........................................................................................................................................................................105
1. Pulmonaal ventilatie: ...........................................................................................................................................105
2. Pulmonaal: sputummobilisatie ...................................................................................................................................105
3. Pulmonaal: hulpmiddelen...........................................................................................................................................106
4. Pulmonaal: zuurstoftoedoening .................................................................................................................................106
5. Oefentherapie.............................................................................................................................................................106
Behandeling veel voorkomende pathologieën ...................................................................................................... 108
Pneumonie...........................................................................................................................................................................108
Atlectase ..............................................................................................................................................................................108
COPD ....................................................................................................................................................................................108
11. ORGANISATIE OUDEREN ZORG ...................................................................................................................................... 110
Toename nood residentiële zorg............................................................................................................................ 110
Residentiele opvang .............................................................................................................................................................110
Belangrijkste diensten van langdurige zorg..........................................................................................................................110
Tewerkstelling kinesitherapeuten in residentiële zorg ........................................................................................... 110
Woonzorgcentra ..................................................................................................................................................................110
Hulpbehoevendheid als maatstaf .......................................................................................................................... 112
Categorieën van zorgbehoevendheid ..................................................................................................................................112
Nomenclatuur ....................................................................................................................................................... 113
Zelfstandige kine ..................................................................................................................................................................113
M-nomenclatuur ..................................................................................................................................................................113
K-nomenclatuur ...................................................................................................................................................................114
F-pathologie .........................................................................................................................................................................114
Gangrevalidatie bij patiënten .........................................................................................................................................114
Voorzieningen ........................................................................................................................................................ 115
Woonzorgcentra (en rust- en verzorgingstehuizen) .............................................................................................................115
Centra voor kortverblijf (CKV) ..............................................................................................................................................115
Dagverzorgingscentra ..........................................................................................................................................................115
Dagverzorgingscentra voor palliatieve verzorging ...............................................................................................................115
Centra voor herstelverblijf ...................................................................................................................................................115
Serviceflats en assistentiewoningen ....................................................................................................................................115
Dienst geriatrie in een algemeen ziekenhuis (G-dienst) ......................................................................................................116
Interne liaison ......................................................................................................................................................................116
Kwaliteitszorg ........................................................................................................................................................ 117
Referentiekader voor de woonzorgcentra ...........................................................................................................................117
BELRAI ..................................................................................................................................................................................117
Sectorspecifieke minimale kwaliteitseisen ..........................................................................................................................118
Taak kinesitherapeut in de ouderenzorg ............................................................................................................... 118
Hoofddoel ............................................................................................................................................................................118
Wet op de uitvoering van de kinesitherapie (WUK) .............................................................................................................118
Specifieke opdrachten kine ..................................................................................................................................................118
Taken binnen het multidisciplinaire team ............................................................................................................................119
Interdisciplinair overleg .......................................................................................................................................................119
Taken ....................................................................................................................................................................................119
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller karenmeesters. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $15.12. You're not tied to anything after your purchase.
